
Zolibac500 mg/5 m
Square Pharmaceuticals PLC.
Cefazolin is a first-generation cephalosporin antibiotic used to treat and prevent infections caused by susceptible bacteria.
Cefazolin is a first-generation cephalosporin antibiotic used to treat and prevent infections caused by susceptible bacteria. Its indications are classified below by strength of evidence.
Cefazolin is not effective against methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa, or most gram-negative anaerobes. Culture and susceptibility testing should guide therapy whenever possible.
Dosage of Cefazolin is individualized according to the site and severity of infection, susceptibility of the causative organism, and renal function.
| Indication | Usual adult dose |
|---|---|
| Mild to moderate infections (skin/soft tissue, respiratory, biliary, urinary) | 250 mg–1 g IV or IM every 8 hours |
| Moderate to severe infections | 500 mg–1 g IV or IM every 6–8 hours |
| Severe, life-threatening infections (e.g., endocarditis, bacteremia) | 1–1.5 g IV every 6 hours (up to 12 g/day under close monitoring) |
| Uncomplicated urinary tract infection | 1 g IV or IM every 12 hours |
| Surgical prophylaxis | 1–2 g IV within 60 minutes before incision; an additional intraoperative dose if surgery exceeds 4 hours or with major blood loss; a higher weight-based dose may be used in obese patients per institutional protocol |
25–100 mg/kg/day IV or IM in 3–4 divided doses depending on severity of infection, not exceeding the maximum adult dose. Safety and efficacy in neonates (under 1 month) have not been established.
Cefazolin is renally cleared and dosage must be reduced in renal impairment based on creatinine clearance; a physician or pharmacist should individualize adjustment. Patients on hemodialysis require a supplemental dose after each dialysis session.
Cefazolin may be given by direct slow IV injection, intermittent IV infusion in a compatible diluent, or deep intramuscular injection. It must be reconstituted/diluted as directed before use (see Reconstitution).
Important: Receive Cefazolin exactly as prescribed by your physician; do not stop, extend, skip doses, or share this medicine with others without medical advice.
The most commonly reported adverse effects of Cefazolin include:
Less common but serious effects include Clostridioides difficile-associated diarrhea/colitis (which can occur during or after treatment with Cefazolin, even weeks post-discontinuation), anaphylaxis and other severe hypersensitivity reactions, and, rarely, seizures with very high doses of Cefazolin, particularly in patients with renal impairment. Seek prompt medical attention for severe or persistent symptoms.
Cefazolin is contraindicated in patients with:
Patients with a history of severe, immediate-type hypersensitivity (e.g., anaphylaxis, angioedema) to penicillins or other beta-lactam antibiotics should receive Cefazolin only with caution and close monitoring (see Precautions and Warnings), as this is a relative rather than absolute contraindication.
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.